Skip to main
EVMN

Evommune Inc (EVMN) Earnings Dates & Reports

Evommune Inc (EVMN) Most Recent Earnings

Report Date
Period EndingQ4 2025
Est. EPS-$0.75
Actual EPS-$1.43
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Evommune Inc (EVMN) Earnings per Share (EPS) History

Signup for full access
Browse free

Evommune Inc (EVMN) Latest Earnings

The value each EVMN share was expected to gain vs. the value each share gained.

Evommune Inc (EVMN) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$1.43. This exceeded analysts' expectations of -$0.75 by 90.67%, marking a Miss.

For comparison, Evommune Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.69.

Evommune Inc (EVMN) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026
-$0.69
Q4 2025
-$0.75-$1.43+90.67%

Evommune Inc (EVMN) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Evommune Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Evommune Inc (EVMN) Earnings FAQs

Evommune Inc (EVMN) last reported earnings on Mar 5, 2026 for Q4 2025, posting an EPS of -$1.43, which Miss the estimate of -$0.75 by 90.67%.

For Q4 2025, Evommune Inc (EVMN) reported an EPS of -$1.43, missing analysts' estimate of -$0.75 by 90.67%.

For Q4 2025, Evommune Inc (EVMN) Miss expectations with an actual EPS of -$1.43 vs. an estimated EPS of -$0.75.

Following the last earnings report on Mar 5, 2026, Evommune Inc (EVMN)'s stock price moved — from — to —.

The next Evommune Inc (EVMN) earnings call is scheduled for May. 7, 2026, where executives will discuss financial results and outlook.

Evommune Inc (EVMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.